Approval Pathway for Biosimilar and Interchangeable Biological Products; Hearing
Document ID: FDA-2010-N-0477-0001
Comments
Total: 70
-
Ovarian Cancer National Alliance - Comment
Posted : 12/27/2010 ID :FDA-2010-N-0477-0038 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
Hogan Lovells US LLP - Comment
Posted : 12/27/2010 ID :FDA-2010-N-0477-0039 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
Dystonia Medical Research Foundation - Comment
Posted : 12/29/2010 ID :FDA-2010-N-0477-0040 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
Abbott - Comment
Posted : 12/29/2010 ID :FDA-2010-N-0477-0041 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
Teva Pharmaceutical Industries, Ltd. - Comment
Posted : 12/29/2010 ID :FDA-2010-N-0477-0042 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
Sobel Medical Associates, Ltd. - Comment
Posted : 12/29/2010 ID :FDA-2010-N-0477-0043 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
Alliance for Patient Access - Comment
Posted : 12/29/2010 ID :FDA-2010-N-0477-0044 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
RetireSafe - Comment
Posted : 12/29/2010 ID :FDA-2010-N-0477-0045 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
Hemophilia Federation of America - Comment
Posted : 12/29/2010 ID :FDA-2010-N-0477-0046 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
American Medical Association (AMA) - Comment
Posted : 12/29/2010 ID :FDA-2010-N-0477-0047 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
American Society of Hematology - Comment
Posted : 12/29/2010 ID :FDA-2010-N-0477-0048 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
American Society of Hematology (ASH) - Comment
Posted : 12/29/2010 ID :FDA-2010-N-0477-0049 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
Biogen Idec - Comment
Posted : 12/29/2010 ID :FDA-2010-N-0477-0050 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
Amgen Inc. - Comment
Posted : 12/29/2010 ID :FDA-2010-N-0477-0051 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
Dr. Reddy's Laboratories, Inc. - Comment
Posted : 01/03/2011 ID :FDA-2010-N-0477-0052 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
Hospira Inc. - Comment
Posted : 01/03/2011 ID :FDA-2010-N-0477-0054 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
AARP - Comment
Posted : 01/03/2011 ID :FDA-2010-N-0477-0055 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
Blue Cross and Blue Shield Association - Comment
Posted : 01/03/2011 ID :FDA-2010-N-0477-0056 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
Mylan - Comment
Posted : 01/03/2011 ID :FDA-2010-N-0477-0057 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
International Society of Pharmacoepidemiology (ISPE) - Comment
Posted : 01/03/2011 ID :FDA-2010-N-0477-0058 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
Medco Health Solutions - Comment
Posted : 01/03/2011 ID :FDA-2010-N-0477-0059 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
Medco Health Solutions - Comment
Posted : 01/03/2011 ID :FDA-2010-N-0477-0060 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
National Psoriasis Foundation - Comment
Posted : 01/03/2011 ID :FDA-2010-N-0477-0061 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
CVS Caremark Corp. - Comment
Posted : 01/03/2011 ID :FDA-2010-N-0477-0062 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
American Society of Health-System Pharmacists (ASHP) - Comment
Posted : 01/03/2011 ID :FDA-2010-N-0477-0063 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
Novartis - Comment
Posted : 01/03/2011 ID :FDA-2010-N-0477-0064 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
The Alliance for Safe Biologic Medicines - Comment
Posted : 01/03/2011 ID :FDA-2010-N-0477-0065 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
Arthritis Foundation - Comment
Posted : 01/03/2011 ID :FDA-2010-N-0477-0066 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
Celltrion, Inc. - Comment
Posted : 01/03/2011 ID :FDA-2010-N-0477-0067 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
Global Healthy Living Foundation - Testimony
Posted : 01/03/2011 ID :FDA-2010-N-0477-0068 Agency : FDA -
Dec 31,2010 11:59 PM ET